| Name | Title | Contact Details |
|---|
Catasys leads the health care industry in improving health and reducing claims costs for health plan members with behavioral health disorders that cause or exacerbate co-existing medical conditions. OnTrak™, a 52-week intensive outpatient program, treats an overlooked population: members suffering from chronic disorders such as substance dependence, anxiety and depression who rarely seek care. These members cost health plans millions of medical dollars primarily due to preventable ambulance usage, medical ER visits and medical inpatient admissions. Catasys uses a proprietary analytics platform and predictive modeling to identify high utilizers of medical healthcare services with costs that can be significantly reduced by addressing the underlying behavioral health disorder(s). Through proactive outreach, we engage and treat these individuals in our patient-centric program that integrates evidence-based medical interventions, psychosocial skill building and care coaching by nurses.
Westchester Medical Center is the premier provider of advanced medical care in New York`s Hudson Valley region. The flagship of the Westchester Medical Center Health Network, this 895-bed academic hospital located in Valhalla, New York, provides local residents with acute care services - Level I trauma and burn care, organ transplants and advanced neurovascular procedures and more - found nowhere else in the region. Westchester Medical Center is the primary referral facility for other hospitals in the Hudson Valley and serves as a lifeline for more than 3.5 million people.
Glytec is the insulin management software company for healthcare providers focused on improving the quality and cost of care. Its FDA-cleared titration software and proprietary algorithms power the only solution capable of delivering personalized diabetes treatment recommendations across the continuum of care, from hospital to home. With ongoing support from its team of doctors, nurses and technologists headquartered outside of Boston, Glytec improves outcomes and controls costs for the large population of patients requiring insulin treatment – including those with and without a diagnosis of diabetes.
MWDN Ltd is a New York, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Polyvue Technologies is a Sacramento, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.